[HTML][HTML] Towards frailty biomarkers: Candidates from genes and pathways regulated in aging and age-related diseases
AL Cardoso, A Fernandes, JA Aguilar-Pimentel… - Ageing research …, 2018 - Elsevier
Objective Use of the frailty index to measure an accumulation of deficits has been proven a
valuable method for identifying elderly people at risk for increased vulnerability, disease …
valuable method for identifying elderly people at risk for increased vulnerability, disease …
The multifaceted role of iron in renal health and disease
RPL van Swelm, JFM Wetzels… - Nature Reviews …, 2020 - nature.com
Iron is an essential element that is indispensable for life. The delicate physiological body
iron balance is maintained by both systemic and cellular regulatory mechanisms. The iron …
iron balance is maintained by both systemic and cellular regulatory mechanisms. The iron …
Fibroblast growth factor 21—metabolic role in mice and men
H Staiger, M Keuper, L Berti… - Endocrine …, 2017 - academic.oup.com
Since its identification in 2000, the interest of scientists in the hepatokine fibroblast growth
factor (FGF) 21 has tremendously grown, and still remains high, due to a wealth of very …
factor (FGF) 21 has tremendously grown, and still remains high, due to a wealth of very …
[HTML][HTML] Circulating FGF21 levels in human health and metabolic disease
M Keuper, HU Häring, H Staiger - Experimental and Clinical …, 2020 - thieme-connect.com
Human fibroblast growth factor 21 (FGF21) is primarily produced and secreted by the liver as
a hepatokine. This hormone circulates to its target tissues (eg, brain, adipose tissue), which …
a hepatokine. This hormone circulates to its target tissues (eg, brain, adipose tissue), which …
Fibroblast growth factor 21 in chronic kidney disease
Abstract Fibroblast growth factor 21 (FGF21) is a member of the endocrine FGF family that
acts as a metabolic regulator of both glucose and lipid metabolism. Similar to fibroblast …
acts as a metabolic regulator of both glucose and lipid metabolism. Similar to fibroblast …
Role of hepcidin-25 in chronic kidney disease: anemia and beyond
N Ueda, K Takasawa - Current medicinal chemistry, 2017 - ingentaconnect.com
Iron is an essential element for all living organisms, but produces toxic oxidants. Thus, iron
homeostasis is tightly regulated in mammals. Hepcidin-25 (hepcidin) has emerged as a …
homeostasis is tightly regulated in mammals. Hepcidin-25 (hepcidin) has emerged as a …
[HTML][HTML] Serum fibroblast growth factor 21 levels is associated with lower extremity atherosclerotic disease in Chinese female diabetic patients
X Zhang, Y Hu, H Zeng, L Li, J Zhao, J Zhao… - Cardiovascular …, 2015 - Springer
Background Fibroblast growth factor 21 (FGF21) is an emerging metabolic regulator
associated with glucose and lipid metabolism, and it is still unclear whether FGF21 is related …
associated with glucose and lipid metabolism, and it is still unclear whether FGF21 is related …
In-depth review: is hepcidin a marker for the heart and the kidney?
Iron is an essential trace element involved in oxidation–reduction reactions, oxygen
transport and storage, and energy metabolism. Iron in excess can be toxic for cells, since …
transport and storage, and energy metabolism. Iron in excess can be toxic for cells, since …
[PDF][PDF] Hepcidin in chronic kidney disease: not an anaemia management tool, but promising as a cardiovascular biomarker
NC Van der Weerd, MP Grooteman, MJ Nubé… - Neth J Med, 2015 - njmonline.nl
Hepcidin is a key regulator of iron homeostasis and plays a role in the pathogenesis of
anaemia of chronic disease. Its levels are increased in patients with chronic kidney disease …
anaemia of chronic disease. Its levels are increased in patients with chronic kidney disease …
Arterial stiffness and increased cardiovascular risk in chronic kidney disease
Y Ma, L Zhou, J Dong, X Zhang, S Yan - International urology and …, 2015 - Springer
Chronic kidney disease (CKD) is a global public health problem. Cardiovascular disease
(CVD) is a common comorbidity and a major cause of mortality in CKD population. While …
(CVD) is a common comorbidity and a major cause of mortality in CKD population. While …